Detalhe da pesquisa
1.
Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor-associated neurotoxicity.
Cancer Med
; 12(8): 9373-9383, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794673
2.
Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy.
J Oncol
; 2020: 8865054, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33381178